查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2088671

呼吸輔助設備市場：2026-2032年全球市場預測（依交付方式、設備類型、患者介面系統、應用、醫療機構、病患年齡層和分銷管道分類）

Respiratory Assist Devices Market by Offering, Device Type, Patient Interface, Application, Care Setting, Patient Age Group, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，呼吸支援設備市場將成長至 371.7 億美元，複合年成長率為 7.06%。

主要市場統計數據
基準年 2025 230.4億美元
預計年份：2026年 245.7億美元
預測年份 2032 371.7億美元
複合年成長率 (%) 7.06%

呼吸輔助設備市場執行摘要

呼吸支援設備，包括非侵入性和人工呼吸器、持續性正壓呼吸器（CPAP）和雙水平氣道正壓通氣（BiPAP）系統、氧氣濃縮機、加濕器、呼吸道清潔系統以及配套的監測設備，構成了現代呼吸護理的核心。沉重的疾病負擔推動了對這些設備的需求。世界衛生組織（WHO）將慢性阻塞性肺病（COPD）列為全球主要死因之一，2019年報告的死亡人數高達323萬人。同時，由於氣喘、肺炎、睡眠呼吸障礙和急性呼吸衰竭等疾病，對及時呼吸支持的需求持續成長。

一項變革性的改變，將改變呼吸照護的提供方式。

呼吸支持設備市場格局正受到三大結構性變革的重塑：醫療服務的去中心化、設備的互聯互通以及供應鏈的韌性。儘管醫院對高級人工呼吸器和高流量氧氣療法的需求依然旺盛，但保險公司和臨床醫生越來越重視居家持續氣道正壓通氣（CPAP）、雙水平氣道正壓通氣（BiPAP）、攜帶式氧氣濃縮機和遠端監測，以減少不必要的再入院，並支持慢性呼吸系統疾病的管理。

人工智慧（AI）的累積影響

人工智慧正透過更智慧的壓力微調、洩漏檢測、預測性警報、患者依從性分析和臨床決策來支持，對呼吸支持設備日益顯著的影響。在睡眠治療中，透過演算法調節氣道壓力可以提高舒適度和依從性，而互聯平台則使臨床醫生無需頻繁面對面會診即可識別殘餘呼吸中止事件、面罩不合適和治療不足等問題。

關於呼吸支援設備的關鍵區域見解

由於亞太地區患者數量龐大、都市區空氣污染嚴重、醫療保健服務可近性不斷提高，以及中國、印度、日本、韓國和澳洲等國國內製造業的擴張，該地區成為呼吸支援設備的重要優先市場。世界衛生組織一直指出空氣污染與呼吸系統和心血管疾病發病率之間存在關聯，這推動了對氧氣療法、非侵入性通氣和長期呼吸護理的需求。北美地區仍然是一個技術密集地區，這得益於完善的保險報銷體系、對阻塞型睡眠呼吸中止症中止症較高的診斷意識、強大的居家照護網路以及對聯網呼吸監測的持續需求。

經濟與政策集團主要群體分析

受醫院現代化、私人醫療網路擴張、都市區空氣污染相關呼吸系統疾病治療需求增加以及主要大都會圈攜帶式氧氣療法和非侵入性通氣需求成長等因素的推動，東協市場持續成長。海灣合作理事會（GCC）各國正優先發展先進的醫院基礎設施、重症監護能力、高品質的居家照護服務以及數位化醫療一體化，同時配合國家醫療改革計劃和對專科醫療服務的廣泛投資。

主要市場的關鍵國別洞察

美國在互聯睡眠療法、家庭氧氣療法和先進的ICU呼吸器呼吸系統護理處於通路，這得益於其強大的臨床基礎設施、FDA的監管、完善的耐用醫療設備主導管道以及民眾對睡眠呼吸障礙的高度關注。加拿大優先考慮公平獲取醫療服務、提高省級政府的採購效率以及為分散居住的人口提供遠端醫療。同時，墨西哥和巴西的需求隨著醫院擴建、對私人醫療保健的投資以及慢性呼吸系統疾病的管理而不斷成長。在歐洲，英國、德國、法國、義大利和西班牙專注於基於指南的呼吸護理、家庭呼吸機計畫、睡眠呼吸中止症候群的治療路徑以及符合歐盟和英國的醫療設備要求。另一方面，俄羅斯則保持對救生技術和國內供應鏈的需求。

為行業領導者提供的實用建議

產業領導醫療設備應優先考慮經臨床驗證的連接性、可維護性和以患者為中心的設計。能夠降低安裝複雜性、提高舒適度、減少噪音、增強便攜性並提供有關治療依從性和通氣情況的可操作數據的醫療設備，既能改善醫療服務提供者和居家照護機構的治療效果，又能滿足尋求可衡量價值的支付方的期望。

調查方法

本執行摘要採用系統性的一手和二手研究方法編寫，符合實證市場情報分析方法。二手研究資料包括來自世界衛生組織 (WHO)、美國疾病管制與預防中心 (CDC)、美國食品藥物管理局 (FDA)、歐洲藥品管理局 (EMA) 等公共機構和國家衛生機構的公共衛生數據、同行評審文獻、醫療設備法規、臨床指南、報銷標準、不利事件資料庫以及公開的行業資訊。

結論

呼吸支援設備市場正朝著更互聯互通、更具韌性、以患者為中心的方向發展。推動市場擴張的因素包括慢性呼吸系統疾病的流行、人口老化、睡眠呼吸中止症的診斷、緊急準備、氧氣基礎設施投資以及家庭呼吸護理的普及。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 呼吸輔助設備市場：依產品/服務分類

  • 正壓通氣（PAP）裝置
    • 持續性陽壓呼吸器（CPAP）裝置
    • 自動正壓通氣（APAP）裝置
    • 雙級正壓通氣（BiPAP）裝置
  • 人工呼吸器
  • 口罩和介面
    • 鼻罩
    • 全臉面罩
  • 復甦裝置
  • 氣道清除輔助裝置
  • 解決方案
    • 遠端監控
    • 資料管理
  • 服務
    • 維護和支援
    • 校對

第8章 呼吸輔助設備市場：依設備類型分類

  • 固定式
  • 桌面
  • 可攜式的

第9章 呼吸輔助設備市場：依患者介面系統

  • 鼻腔介面
  • 口腔面
  • 侵入性氣道介面
    • 氣管插管
    • 氣切管

第10章 呼吸輔助設備市場：依應用分類

  • 慢性阻塞性肺病（COPD）
  • 急診和創傷護理
  • 睡眠呼吸中止症治療
    • 中樞性睡眠呼吸中止症
    • 阻塞型睡眠呼吸中止症
  • 呼吸衰竭
    • 急性
    • 慢性的
  • 新生兒呼吸系統疾病

第11章 呼吸輔助設備市場：依護理環境分類

  • 醫院
  • 專科診所
  • 家庭醫療保健
  • 門診部

第12章 呼吸輔助設備市場：依病患年齡層別分類

  • 兒童
  • 成人
  • 老年人
  • 新生
  • 嬰兒

第13章 呼吸輔助設備市場：依通路分類

  • 線下銷售
  • 線上銷售
    • 製造商網站
    • 電子商務平台

第14章 呼吸輔助設備市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第15章 呼吸輔助設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 呼吸輔助設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第18章：公司簡介

  • ResMed Inc.
  • Fisher & Paykel Healthcare Limited
  • Koninklijke Philips NV
  • Getinge AB
  • Dragerwerk AG & Co. KGaA
  • GE HealthCare Technologies Inc.
  • Medtronic plc
  • Hamilton Medical AG
  • SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
  • Inogen Inc.
  • Baxter International Inc.
  • Drive DeVilbiss Healthcare Ltd.
  • PARI GmbH
  • Lowenstein Medical SE & Co. KG
  • React Health
  • AdaptHealth, LLC
  • Air Liquide SA
  • AirLife
  • Apex Medical Devices
  • BMC Medical Co. Ltd.
  • Breas Medical AB
  • Cardinal Health, Inc.
  • Masimo Corporation
  • Medline Industries, LP
  • Natus Medical Incorporated
  • Nihon Kohden Corporation
  • OMRON Healthcare, Inc.
  • Schiller AG
  • Shenyang Canta Medical Tech Co., Ltd.
  • Smiths Group plc
  • TE Connectivity plc
  • Teijin Limited
  • Teleflex Incorporated
  • ZOLL Medical Corporation
Product Code: MRR-A339DAEFA826

The Respiratory Assist Devices Market is projected to grow by USD 37.17 billion at a CAGR of 7.06% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 23.04 billion
Estimated Year [2026] USD 24.57 billion
Forecast Year [2032] USD 37.17 billion
CAGR (%) 7.06%

Respiratory Assist Devices Market Executive Summary

Respiratory assist devices are central to modern respiratory care, spanning non-invasive ventilation, invasive ventilators, CPAP and BiPAP systems, oxygen concentrators, humidifiers, airway clearance systems, and connected monitoring accessories. Demand is anchored by a substantial disease burden: the World Health Organization identifies chronic obstructive pulmonary disease as a leading global cause of death, with 3.23 million deaths reported in 2019, while asthma, pneumonia, sleep-disordered breathing, and acute respiratory failure continue to increase the need for timely respiratory support.

The market is moving from hospital-centered critical care toward a broader continuum that includes emergency transport, long-term care, and home respiratory therapy. Aging populations, higher survival rates among patients with chronic cardiopulmonary disease, and the post-pandemic emphasis on oxygen availability, ventilator readiness, and non-invasive respiratory support are increasing procurement attention across health systems, payers, and homecare providers.

Transformative Shifts Reshaping Respiratory Care

The respiratory assist devices landscape is being reshaped by three structural shifts: care decentralization, device connectivity, and supply chain resilience. Hospitals continue to require advanced ventilators and high-flow oxygen support, but payers and clinicians are increasingly prioritizing home-based CPAP, BiPAP, portable oxygen concentrators, and remote monitoring to reduce avoidable readmissions and support chronic respiratory disease management.

Regulatory and procurement priorities are also changing. The COVID-19 response exposed vulnerabilities in oxygen infrastructure, ventilator availability, and component sourcing, prompting governments and providers to diversify suppliers, strengthen service networks, and validate device performance under emergency-use and routine-care conditions. Manufacturers that combine clinical reliability, interoperability, cybersecurity readiness, and lifecycle service support are best positioned for sustained adoption.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is increasingly influencing respiratory assist devices through smarter pressure titration, leak detection, predictive alarms, patient adherence analytics, and clinical decision support. In sleep therapy, algorithmic adjustment of airway pressure can improve comfort and adherence, while connected platforms help clinicians identify residual apnea events, mask fit issues, and therapy gaps without requiring frequent in-person visits.

In acute and critical care, AI-enabled analytics can support earlier detection of patient-ventilator asynchrony, deterioration risk, and weaning readiness. These applications do not replace clinical judgment, but they can reduce alarm fatigue, improve workflow efficiency, and enable more personalized respiratory support when validated with high-quality clinical data, cybersecurity controls, bias monitoring, and transparent performance governance.

Key Regional Insights for Respiratory Assist Devices

Asia-Pacific is a high-priority region for respiratory assist devices because of large patient populations, urban air pollution exposure, rising healthcare access, and expanding domestic manufacturing in China, India, Japan, South Korea, and Australia. The WHO has consistently linked air pollution exposure with respiratory and cardiovascular morbidity, reinforcing demand for oxygen therapy, non-invasive ventilation, and long-term respiratory care. North America remains a technology-intensive region, supported by established reimbursement pathways, high diagnostic awareness for obstructive sleep apnea, strong homecare networks, and sustained demand for connected respiratory monitoring.

Latin America is expanding through public hospital upgrades, private provider investment, and broader adoption of oxygen therapy in Brazil and Mexico, particularly for chronic respiratory disease and acute care readiness. Europe benefits from advanced clinical guidelines, a strong home respiratory care base, mature sleep medicine pathways, and procurement focus on energy efficiency, patient safety, and regulatory compliance. The Middle East is investing in tertiary care capacity, intensive care infrastructure, and medical tourism-linked specialty services, while Africa's opportunity is closely tied to oxygen access, affordability, biomedical engineering capacity, local maintenance models, and reliable power supply for respiratory support systems.

Key Group Insights Across Economic and Policy Blocs

ASEAN markets are advancing through hospital modernization, growing private healthcare networks, urban pollution-related respiratory needs, and increasing demand for portable oxygen and non-invasive ventilation in major metropolitan centers. GCC countries are prioritizing advanced hospital infrastructure, intensive care capacity, premium homecare services, and digital health integration aligned with national healthcare transformation programs and broader investment in specialized care delivery.

The European Union emphasizes harmonized medical device regulation, clinical evidence, traceability, and post-market surveillance under the MDR framework, creating a premium for compliant and well-documented respiratory technologies. BRICS markets combine large respiratory disease burdens, air quality challenges, expanding healthcare access, and manufacturing ambitions, while the G7 leads in connected care adoption, reimbursement sophistication, clinical research capacity, and high-acuity respiratory innovation. NATO-aligned procurement considerations increasingly emphasize emergency preparedness, supply continuity, deployable respiratory support, and resilient medical logistics for crisis response.

Key Country Insights for Priority Markets

The United States leads in connected sleep therapy, home oxygen services, and advanced ICU ventilation, supported by strong clinical infrastructure, FDA oversight, established durable medical equipment channels, and high awareness of sleep-disordered breathing. Canada prioritizes equitable access, provincial procurement efficiency, and remote care delivery across dispersed populations, while Mexico and Brazil show rising demand through hospital expansion, private healthcare investment, and chronic respiratory disease management. In Europe, the United Kingdom, Germany, France, Italy, and Spain emphasize guideline-led respiratory care, home ventilation programs, sleep apnea treatment pathways, and compliance with EU or UK medical device requirements, while Russia maintains demand for critical care technologies and domestically supported supply chains.

China and India are scale markets shaped by large populations, air quality concerns, expanding hospital networks, and growing domestic production of oxygen and ventilation technologies. Japan and South Korea support high-quality respiratory care through aging-population needs, advanced electronics ecosystems, strong hospital capabilities, and established standards for device quality and patient safety. Australia combines mature reimbursement, rural and remote care challenges, and demand for reliable portable oxygen concentrators, CPAP systems, and non-invasive ventilation devices that support home-based respiratory therapy.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated connectivity, serviceability, and patient-centered design. Devices that reduce setup complexity, improve comfort, limit noise, enhance portability, and provide actionable adherence or ventilation data can strengthen outcomes for providers and homecare organizations while supporting payer expectations for measurable value.

Manufacturers should also diversify component sourcing, invest in regional service hubs, strengthen biomedical engineering training, and align product portfolios with local oxygen infrastructure realities. Strategic partnerships with hospitals, sleep labs, distributors, emergency preparedness agencies, and digital health platforms can accelerate adoption, but success will depend on cybersecurity, regulatory readiness, transparent AI validation, usability testing, and robust post-market surveillance.

Research Methodology

This executive summary is developed through a structured secondary and primary research approach aligned with evidence-based market intelligence practices. Secondary inputs include public health data from recognized authorities such as the WHO, CDC, FDA, EMA, national health agencies, peer-reviewed literature, medical device regulations, clinical guidelines, reimbursement references, adverse event databases, and publicly available industry disclosures.

Primary validation typically incorporates expert interviews across manufacturers, distributors, clinicians, respiratory therapists, biomedical engineers, procurement leaders, and homecare service providers. Findings are triangulated across disease burden, technology adoption, regulatory pathways, installed base indicators, supply chain signals, clinical use cases, and regional healthcare investment to produce evidence-led interpretation without relying on market sizing, market share, or forecasting.

Conclusion

The respiratory assist devices market is entering a more connected, resilient, and patient-centric phase. Adoption is supported by chronic respiratory disease prevalence, aging demographics, sleep apnea diagnosis, emergency preparedness, oxygen infrastructure investment, and the expansion of home-based respiratory care.

Competitive advantage will increasingly depend on validated clinical performance, reliable supply, digital interoperability, AI governance, cybersecurity, usability, and strong service infrastructure. Companies that combine high-acuity innovation with affordable, scalable respiratory support solutions will be best positioned to meet global healthcare needs across hospitals, emergency settings, long-term care, and home therapy environments.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Respiratory Assist Devices Market, by Offering

  • 7.1. Positive Airway Pressure (PAP) Devices
    • 7.1.1. Continuous Positive Airway Pressure (CPAP) Devices
    • 7.1.2. Automatic Positive Airway Pressure (APAP) Devices
    • 7.1.3. Bilevel Positive Airway Pressure (BiPAP) Devices
  • 7.2. Ventilators
  • 7.3. Mask & Interfaces
    • 7.3.1. Nasal Masks
    • 7.3.2. Full Face Masks
  • 7.4. Resuscitation Devices
  • 7.5. Airway Clearance Assist Devices
  • 7.6. Solutions
    • 7.6.1. Remote Monitoring
    • 7.6.2. Data Management
  • 7.7. Services
    • 7.7.1. Maintenance & Support
    • 7.7.2. Calibration

8. Respiratory Assist Devices Market, by Device Type

  • 8.1. Stationary
  • 8.2. Tabletop
  • 8.3. Portable

9. Respiratory Assist Devices Market, by Patient Interface

  • 9.1. Nasal Interfaces
  • 9.2. Oral Interfaces
  • 9.3. Invasive Airway Interfaces
    • 9.3.1. Endotracheal Tube
    • 9.3.2. Tracheostomy Tube

10. Respiratory Assist Devices Market, by Application

  • 10.1. Chronic Obstructive Pulmonary Disease (COPD)
  • 10.2. Emergency & Trauma Care
  • 10.3. Sleep Apnea Therapy
    • 10.3.1. Central Sleep Apnea
    • 10.3.2. Obstructive Sleep Apnea
  • 10.4. Respiratory Failure
    • 10.4.1. Acute
    • 10.4.2. Chronic
  • 10.5. Neonatal Respiratory Disorders

11. Respiratory Assist Devices Market, by Care Setting

  • 11.1. Hospitals
  • 11.2. Specialty Clinics
  • 11.3. Home Healthcare
  • 11.4. Ambulatory Care Centers

12. Respiratory Assist Devices Market, by Patient Age Group

  • 12.1. Pediatric
  • 12.2. Adult
  • 12.3. Geriatric
  • 12.4. Neonatal
  • 12.5. Infant

13. Respiratory Assist Devices Market, by Distribution Channel

  • 13.1. Offline Sales
  • 13.2. Online Sales
    • 13.2.1. Manufacturer Websites
    • 13.2.2. eCommerce Platforms

14. Respiratory Assist Devices Market, by Region

  • 14.1. Asia-Pacific
  • 14.2. North America
  • 14.3. Latin America
  • 14.4. Europe
  • 14.5. Middle East
  • 14.6. Africa

15. Respiratory Assist Devices Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Respiratory Assist Devices Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025

18. Company Profiles

  • 18.1. ResMed Inc.
  • 18.2. Fisher & Paykel Healthcare Limited
  • 18.3. Koninklijke Philips N.V.
  • 18.4. Getinge AB
  • 18.5. Dragerwerk AG & Co. KGaA
  • 18.6. GE HealthCare Technologies Inc.
  • 18.7. Medtronic plc
  • 18.8. Hamilton Medical AG
  • 18.9. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
  • 18.10. Inogen Inc.
  • 18.11. Baxter International Inc.
  • 18.12. Drive DeVilbiss Healthcare Ltd.
  • 18.13. PARI GmbH
  • 18.14. Lowenstein Medical SE & Co. KG
  • 18.15. React Health
  • 18.16. AdaptHealth, LLC
  • 18.17. Air Liquide S.A.
  • 18.18. AirLife
  • 18.19. Apex Medical Devices
  • 18.20. BMC Medical Co. Ltd.
  • 18.21. Breas Medical AB
  • 18.22. Cardinal Health, Inc.
  • 18.23. Masimo Corporation
  • 18.24. Medline Industries, LP
  • 18.25. Natus Medical Incorporated
  • 18.26. Nihon Kohden Corporation
  • 18.27. OMRON Healthcare, Inc.
  • 18.28. Schiller AG
  • 18.29. Shenyang Canta Medical Tech Co., Ltd.
  • 18.30. Smiths Group plc
  • 18.31. TE Connectivity plc
  • 18.32. Teijin Limited
  • 18.33. Teleflex Incorporated
  • 18.34. ZOLL Medical Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL RESPIRATORY ASSIST DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL RESPIRATORY ASSIST DEVICES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL RESPIRATORY ASSIST DEVICES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL RESPIRATORY ASSIST DEVICES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL RESPIRATORY ASSIST DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY OFFERING, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY OFFERING, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT INTERFACE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT INTERFACE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY CARE SETTING, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY CARE SETTING, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 27. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL POSITIVE AIRWAY PRESSURE (PAP) DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL POSITIVE AIRWAY PRESSURE (PAP) DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL POSITIVE AIRWAY PRESSURE (PAP) DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL AUTOMATIC POSITIVE AIRWAY PRESSURE (APAP) DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL AUTOMATIC POSITIVE AIRWAY PRESSURE (APAP) DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL AUTOMATIC POSITIVE AIRWAY PRESSURE (APAP) DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BILEVEL POSITIVE AIRWAY PRESSURE (BIPAP) DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BILEVEL POSITIVE AIRWAY PRESSURE (BIPAP) DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BILEVEL POSITIVE AIRWAY PRESSURE (BIPAP) DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL VENTILATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL VENTILATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL VENTILATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MASK & INTERFACES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL MASK & INTERFACES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL MASK & INTERFACES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NASAL MASKS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NASAL MASKS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NASAL MASKS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL FULL FACE MASKS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL FULL FACE MASKS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL FULL FACE MASKS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL AIRWAY CLEARANCE ASSIST DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL AIRWAY CLEARANCE ASSIST DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL AIRWAY CLEARANCE ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SOLUTIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL SOLUTIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL REMOTE MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL REMOTE MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL REMOTE MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL DATA MANAGEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL DATA MANAGEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL DATA MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL MAINTENANCE & SUPPORT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MAINTENANCE & SUPPORT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MAINTENANCE & SUPPORT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CALIBRATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CALIBRATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CALIBRATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL STATIONARY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL STATIONARY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL STATIONARY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL TABLETOP MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL TABLETOP MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL TABLETOP MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PORTABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PORTABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PORTABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT INTERFACE, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL NASAL INTERFACES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL NASAL INTERFACES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL NASAL INTERFACES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ORAL INTERFACES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ORAL INTERFACES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ORAL INTERFACES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL INVASIVE AIRWAY INTERFACES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL INVASIVE AIRWAY INTERFACES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL INVASIVE AIRWAY INTERFACES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ENDOTRACHEAL TUBE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ENDOTRACHEAL TUBE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ENDOTRACHEAL TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL TRACHEOSTOMY TUBE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL TRACHEOSTOMY TUBE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL TRACHEOSTOMY TUBE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL EMERGENCY & TRAUMA CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL EMERGENCY & TRAUMA CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL EMERGENCY & TRAUMA CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL SLEEP APNEA THERAPY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL SLEEP APNEA THERAPY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL SLEEP APNEA THERAPY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CENTRAL SLEEP APNEA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL CENTRAL SLEEP APNEA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL CENTRAL SLEEP APNEA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL OBSTRUCTIVE SLEEP APNEA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL OBSTRUCTIVE SLEEP APNEA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL OBSTRUCTIVE SLEEP APNEA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL RESPIRATORY FAILURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL RESPIRATORY FAILURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL RESPIRATORY FAILURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ACUTE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ACUTE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ACUTE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL CHRONIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL CHRONIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL CHRONIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL NEONATAL RESPIRATORY DISORDERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL NEONATAL RESPIRATORY DISORDERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL NEONATAL RESPIRATORY DISORDERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL HOME HEALTHCARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL HOME HEALTHCARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL HOME HEALTHCARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL GERIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL GERIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL GERIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL NEONATAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL NEONATAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL NEONATAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL INFANT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL INFANT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL INFANT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL OFFLINE SALES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL OFFLINE SALES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL OFFLINE SALES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL ONLINE SALES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL ONLINE SALES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL ONLINE SALES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL MANUFACTURER WEBSITES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL MANUFACTURER WEBSITES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL MANUFACTURER WEBSITES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL ECOMMERCE PLATFORMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL ECOMMERCE PLATFORMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL ECOMMERCE PLATFORMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC RESPIRATORY ASSIST DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY POSITIVE AIRWAY PRESSURE (PAP) DEVICES, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY MASK & INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT INTERFACE, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY INVASIVE AIRWAY INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SLEEP APNEA THERAPY, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY POSITIVE AIRWAY PRESSURE (PAP) DEVICES, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY MASK & INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 170. NORTH AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. NORTH AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT INTERFACE, 2018-2032 (USD MILLION)
  • TABLE 172. NORTH AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY INVASIVE AIRWAY INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 173. NORTH AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. NORTH AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SLEEP APNEA THERAPY, 2018-2032 (USD MILLION)
  • TABLE 175. NORTH AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2018-2032 (USD MILLION)
  • TABLE 176. NORTH AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 178. NORTH AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY POSITIVE AIRWAY PRESSURE (PAP) DEVICES, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY MASK & INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 185. LATIN AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 186. LATIN AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. LATIN AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT INTERFACE, 2018-2032 (USD MILLION)
  • TABLE 188. LATIN AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY INVASIVE AIRWAY INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 189. LATIN AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. LATIN AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SLEEP APNEA THERAPY, 2018-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2018-2032 (USD MILLION)
  • TABLE 192. LATIN AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 194. LATIN AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE RESPIRATORY ASSIST DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE RESPIRATORY ASSIST DEVICES MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE RESPIRATORY ASSIST DEVICES MARKET SIZE, BY POSITIVE AIRWAY PRESSURE (PAP) DEVICES, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE RESPIRATORY ASSIST DEVICES MARKET SIZE, BY MASK & INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPE RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPE RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPE RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPE RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT INTERFACE, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPE RESPIRATORY ASSIST DEVICES MARKET SIZE, BY INVASIVE AIRWAY INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPE RESPIRATORY ASSIST DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPE RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SLEEP APNEA THERAPY, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPE RESPIRATORY ASSIST DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPE RESPIRATORY ASSIST DEVICES MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPE RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 210. EUROPE RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 211. EUROPE RESPIRATORY ASSIST DEVICES MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST RESPIRATORY ASSIST DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST RESPIRATORY ASSIST DEVICES MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST RESPIRATORY ASSIST DEVICES MARKET SIZE, BY POSITIVE AIRWAY PRESSURE (PAP) DEVICES, 2018-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST RESPIRATORY ASSIST DEVICES MARKET SIZE, BY MASK & INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 216. MIDDLE EAST RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 217. MIDDLE EAST RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 218. MIDDLE EAST RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. MIDDLE EAST RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT INTERFACE, 2018-2032 (USD MILLION)
  • TABLE 220. MIDDLE EAST RESPIRATORY ASSIST DEVICES MARKET SIZE, BY INVASIVE AIRWAY INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 221. MIDDLE EAST RESPIRATORY ASSIST DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. MIDDLE EAST RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SLEEP APNEA THERAPY, 2018-2032 (USD MILLION)
  • TABLE 223. MIDDLE EAST RESPIRATORY ASSIST DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2018-2032 (USD MILLION)
  • TABLE 224. MIDDLE EAST RESPIRATORY ASSIST DEVICES MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 225. MIDDLE EAST RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 226. MIDDLE EAST RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 227. MIDDLE EAST RESPIRATORY ASSIST DEVICES MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA RESPIRATORY ASSIST DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY POSITIVE AIRWAY PRESSURE (PAP) DEVICES, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY MASK & INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 234. AFRICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. AFRICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT INTERFACE, 2018-2032 (USD MILLION)
  • TABLE 236. AFRICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY INVASIVE AIRWAY INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 237. AFRICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 238. AFRICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SLEEP APNEA THERAPY, 2018-2032 (USD MILLION)
  • TABLE 239. AFRICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2018-2032 (USD MILLION)
  • TABLE 240. AFRICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 241. AFRICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 242. AFRICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 243. AFRICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 244. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 245. ASEAN RESPIRATORY ASSIST DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN RESPIRATORY ASSIST DEVICES MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN RESPIRATORY ASSIST DEVICES MARKET SIZE, BY POSITIVE AIRWAY PRESSURE (PAP) DEVICES, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN RESPIRATORY ASSIST DEVICES MARKET SIZE, BY MASK & INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. ASEAN RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT INTERFACE, 2018-2032 (USD MILLION)
  • TABLE 253. ASEAN RESPIRATORY ASSIST DEVICES MARKET SIZE, BY INVASIVE AIRWAY INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 254. ASEAN RESPIRATORY ASSIST DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 255. ASEAN RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SLEEP APNEA THERAPY, 2018-2032 (USD MILLION)
  • TABLE 256. ASEAN RESPIRATORY ASSIST DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2018-2032 (USD MILLION)
  • TABLE 257. ASEAN RESPIRATORY ASSIST DEVICES MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 258. ASEAN RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 259. ASEAN RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 260. ASEAN RESPIRATORY ASSIST DEVICES MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 261. GCC RESPIRATORY ASSIST DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 262. GCC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 263. GCC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY POSITIVE AIRWAY PRESSURE (PAP) DEVICES, 2018-2032 (USD MILLION)
  • TABLE 264. GCC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY MASK & INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 265. GCC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 266. GCC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 267. GCC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. GCC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT INTERFACE, 2018-2032 (USD MILLION)
  • TABLE 269. GCC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY INVASIVE AIRWAY INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 270. GCC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 271. GCC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SLEEP APNEA THERAPY, 2018-2032 (USD MILLION)
  • TABLE 272. GCC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2018-2032 (USD MILLION)
  • TABLE 273. GCC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 274. GCC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 275. GCC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 276. GCC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION RESPIRATORY ASSIST DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION RESPIRATORY ASSIST DEVICES MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION RESPIRATORY ASSIST DEVICES MARKET SIZE, BY POSITIVE AIRWAY PRESSURE (PAP) DEVICES, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPEAN UNION RESPIRATORY ASSIST DEVICES MARKET SIZE, BY MASK & INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 282. EUROPEAN UNION RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 283. EUROPEAN UNION RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPEAN UNION RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT INTERFACE, 2018-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION RESPIRATORY ASSIST DEVICES MARKET SIZE, BY INVASIVE AIRWAY INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 286. EUROPEAN UNION RESPIRATORY ASSIST DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SLEEP APNEA THERAPY, 2018-2032 (USD MILLION)
  • TABLE 288. EUROPEAN UNION RESPIRATORY ASSIST DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2018-2032 (USD MILLION)
  • TABLE 289. EUROPEAN UNION RESPIRATORY ASSIST DEVICES MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 290. EUROPEAN UNION RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 291. EUROPEAN UNION RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 292. EUROPEAN UNION RESPIRATORY ASSIST DEVICES MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 293. BRICS RESPIRATORY ASSIST DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 294. BRICS RESPIRATORY ASSIST DEVICES MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 295. BRICS RESPIRATORY ASSIST DEVICES MARKET SIZE, BY POSITIVE AIRWAY PRESSURE (PAP) DEVICES, 2018-2032 (USD MILLION)
  • TABLE 296. BRICS RESPIRATORY ASSIST DEVICES MARKET SIZE, BY MASK & INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 297. BRICS RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 298. BRICS RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 299. BRICS RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 300. BRICS RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT INTERFACE, 2018-2032 (USD MILLION)
  • TABLE 301. BRICS RESPIRATORY ASSIST DEVICES MARKET SIZE, BY INVASIVE AIRWAY INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 302. BRICS RESPIRATORY ASSIST DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 303. BRICS RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SLEEP APNEA THERAPY, 2018-2032 (USD MILLION)
  • TABLE 304. BRICS RESPIRATORY ASSIST DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2018-2032 (USD MILLION)
  • TABLE 305. BRICS RESPIRATORY ASSIST DEVICES MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 306. BRICS RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 307. BRICS RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 308. BRICS RESPIRATORY ASSIST DEVICES MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 309. G7 RESPIRATORY ASSIST DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 310. G7 RESPIRATORY ASSIST DEVICES MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 311. G7 RESPIRATORY ASSIST DEVICES MARKET SIZE, BY POSITIVE AIRWAY PRESSURE (PAP) DEVICES, 2018-2032 (USD MILLION)
  • TABLE 312. G7 RESPIRATORY ASSIST DEVICES MARKET SIZE, BY MASK & INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 313. G7 RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 314. G7 RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 315. G7 RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 316. G7 RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT INTERFACE, 2018-2032 (USD MILLION)
  • TABLE 317. G7 RESPIRATORY ASSIST DEVICES MARKET SIZE, BY INVASIVE AIRWAY INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 318. G7 RESPIRATORY ASSIST DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 319. G7 RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SLEEP APNEA THERAPY, 2018-2032 (USD MILLION)
  • TABLE 320. G7 RESPIRATORY ASSIST DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2018-2032 (USD MILLION)
  • TABLE 321. G7 RESPIRATORY ASSIST DEVICES MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 322. G7 RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 323. G7 RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 324. G7 RESPIRATORY ASSIST DEVICES MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 325. NATO RESPIRATORY ASSIST DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 326. NATO RESPIRATORY ASSIST DEVICES MARKET SIZE, BY OFFERING, 2018-2032 (USD MILLION)
  • TABLE 327. NATO RESPIRATORY ASSIST DEVICES MARKET SIZE, BY POSITIVE AIRWAY PRESSURE (PAP) DEVICES, 2018-2032 (USD MILLION)
  • TABLE 328. NATO RESPIRATORY ASSIST DEVICES MARKET SIZE, BY MASK & INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 329. NATO RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SOLUTIONS, 2018-2032 (USD MILLION)
  • TABLE 330. NATO RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 331. NATO RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 332. NATO RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT INTERFACE, 2018-2032 (USD MILLION)
  • TABLE 333. NATO RESPIRATORY ASSIST DEVICES MARKET SIZE, BY INVASIVE AIRWAY INTERFACES, 2018-2032 (USD MILLION)
  • TABLE 334. NATO RESPIRATORY ASSIST DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 335. NATO RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SLEEP APNEA THERAPY, 2018-2032 (USD MILLION)
  • TABLE 336. NATO RESPIRATORY ASSIST DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2018-2032 (USD MILLION)
  • TABLE 337. NATO RESPIRATORY ASSIST DEVICES MARKET SIZE, BY CARE SETTING, 2018-2032 (USD MILLION)
  • TABLE 338. NATO RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 339. NATO RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 340. NATO RESPIRATORY ASSIST DEVICES MARKET SIZE, BY ONLINE SALES, 2018-2032 (USD MILLION)
  • TABLE 341. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 342. UNITED STATES RESPIRATORY ASSIST DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 343. UNITE